findmyKOL
Clinical trialNCT06950892RecruitingObservational

Remote Sputum Collection in Cystic Fibrosis

SponsorUniversity of PennsylvaniaEnrollment150Cystic FibrosisInfections
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Elexacaftor/Tezacaftor/Ivacaftor or Trikafta improves lung health in people with cystic fibrosis (CF), including decreased cough and mucous production. Diagnosing lung infections has become more challenging due to the decrease in sputum and rise of telehealth services. While the option of collecting sputum samples at home and sending them by mail may be feasible, uncertainty remains about how the collection of samples outside of clinic and delays in testing while in the mail impact infection detection. This study will compare bacterial cultures using sputum samples collected at home versus samples collected in clinic (saline-induced sputum and throat swab). This study seeks to shed light on how valuable home collected samples can be and help us better understand the usefulness of home-collected sputum samples for both clinical and research purposes.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • National Jewish Health

    Denver, Colorado, United States

    Milene Saveedra, MD
    Recruiting
  • Johns Hopkins University

    Baltimore, Maryland, United States

    Noah Lechtzin, MD
    Recruiting
  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Gina Hong, MD
    Recruiting
  • Providence Medical Research Center

    Spokane, Washington, United States

    Allison Lambert, MD, MHS
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Jan 2025
Primary completion
30 Jun 2027
Completion
30 Jun 2028
Last update posted
19 Aug 2026
Registered enrollment
150
Registry id
NCT06950892

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.